Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 2008

View Archived Issues

Memory presents an update on the company's collaborative and proprietary clinical programs

Novel antiangiogenic agent profiled at Amgen

Researchers identify novel inhibitors of orphan SF-1 nuclear receptor

Antimalarial agent may be useful for the treatment of toxoplasmosis

Eisai submits application in Japan for oral jelly formulation of Aricept in Alzheimer's disease

Lilly and Transition enter agreement for TT-223 and other gastrin-based therapies in diabetes

Neurochem to initiate second phase III clinical trial of Kiacta in amyloid A amyloidosis

Power3 initiates clinical validation study of NuroPro in Alzheimer's and Parkinson's disease

Teva reports negative final results from a phase II trial of glatiramer acetate in ALS

FDA grants approval to Diamyd to initiate phase III clinical study of Diamyd in diabetes

FDA licenses sanofi-aventis' Daptacel as fifth consecutive DTaP vaccine dose for children

Silence and AstraZeneca to collaborate in developing novel delivery systems for siRNA molecules

Jazz presents an update on pipeline progress

New treatments for inflammatory conditions such as rheumatoid arthritis claimed in recent patents

Novel analgesic agents disclosed in recent Boehringer Ingelheim and GSK patents

EntreMed presents update on clinical programs

Abraxis files marketing application for Abraxane for breast cancer in Japan

Novel botulinum toxin type A treatment improves aspects of plantar fasciitis

Benefits lasting 6 months seen with duloxetine in fibromyalgia patients

Nuvelo to discontinue alfimeprase development

FDA issues approvable letter for ceftobiprole, an anti-MRSA broad-spectrum antibiotic

Studies point to lacosamide efficacy in painful diabetic neuropathy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...